Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Buy
170
+120
+240% +$208K 3.34% 5
2026
Q2
$99.5K Buy
+50
New +$79.6K 2.46% 14
2024
Q1
$5.3M Sell
5,458
-5,249
-49% -$4.66M 0.79% 34
2023
Q4
$8.1M Hold
10,707
– – 1.5% 29
2023
Q3
$6.3M Buy
10,707
+2,785
+35% +$1.85M 1.38% 29
2023
Q2
$5.74M Sell
7,922
-4,649
-37% -$3.16M 1.32% 31
2023
Q1
$8.56M Buy
12,571
+1,863
+17% +$1.2M 2.17% 19
2022
Q4
$5.85M Buy
+10,708
New +$5.61M 1.67% 27

Other funds holding ASML

Compound Global Advisors's ASML Position: Q3 2026 in Review

Compound Global Advisors increased its ASML (ASML) stake by 240% in Q3 2026, buying an estimated $208K and bringing the position to 170 shares worth $308K. The position accounts for 3.34% of the portfolio, ranked #5.

Compound Global Advisors first reported a position in ASML in Q4 2022 and has held it in 8 quarters since. The position peaked at $8.56M in Q1 2023. 540 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Compound Global Advisors held 170 shares of ASML worth $308K as of Q3 2026.
  • Compound Global Advisors bought 120 ASML shares in Q3 2026, an estimated $208K.
  • ASML made up 3.34% of Compound Global Advisors's portfolio in Q3 2026, its #5 holding.
  • Compound Global Advisors first reported a position in ASML in Q4 2022 and has held it in 8 quarters since.
  • Compound Global Advisors's ASML position peaked at $8.56M in Q1 2023.
  • 540 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Compound Global Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.